Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 2 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Cough Syrup - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

In case of cough syrup preparation, there are two methods available. First, method by using allopathic based basic drugs and on the other side, cough syrup can be prepared by using different herbal extracts in certain composition. The demand of cough syrup from herbal extracts is increasing rapidly nowadays, because unlike allopathic drugs, herbal drugs has no side effects. By using the different and various extracts of the herbs, different kind of syrup can be prepared. Herbal cough syrup, a highly effective and well-tolerated one, is the ideal combination of herbal ingredients necessary for the operation. There are few organized as well as private sectors engaged for the production of this. As a whole, the project is good one and the new comers should be well confident about government policy and F. D. A.
Plant capacity: 10000 Bottles /DayPlant & machinery: Rs. 40 Lakhs
Working capital: Rs. 175 LakhsT.C.I: Rs. 300 Lakhs
Return: 46.35%Break even: 37.50%
Add to Inquiry Add to Inquiry Basket

Vitamin C - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Vitamin is crucial component for good health.Vitamins are generated in the body itself however any irregularity or sickness disturbs this automatic generation of vitamins. Vitamin?C is one of the important vitamin require by body. The source of vitamin?C include accerola, citrus fruits, tomatoes, potatoes and green leaf vegetables. At present two units are producing vitamin?C namely Jayant vitamin and Sarabhai. The consumption of vitamin??C is increasing rapidly. Looking to the future demand is estimated to grow at the rate of 8 percent per annum. There is good scope for to install a new unit.
Plant capacity: 1870 MT/AnnumPlant & machinery: Rs. 102.0 Lakhs
Working capital: Rs. 135.0 LakhsT.C.I: Rs. 282.0 Lakhs
Return: 43.07%Break even: 45.21%
Add to Inquiry Add to Inquiry Basket

Dextrose Injection - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Dextrose injection basically is manufactured from the homogeneous solution of dextrose and sterilized water. As raw material, there is abundant availability of dextrose in India. Basic plant and machinery?s as well as good fabricators also are fully available in India. The demand growth of this product is very appreciable. Right now it is increasing at a rate 5 % per annum. Few organized sector are engaged in the production of dextrose. But the demand is gradually increasing. So to meet the gap of demand and production, there require more production units. So this sector may be prospectus one for new entrepreneur. As a whole, this is a good one and one may be successful in this arena.
Plant capacity: 10000 Bottles/DayPlant & machinery: Rs. 82 Lakhs
Working capital: Rs. 151 LakhsT.C.I: Rs. 290 Lakhs
Return: 28.26%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Black Braided Silk Surgical Suture - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Plant Layout

There are so many fibers available which has property of non absorbing among those fibers are nylon, Terelene, Polyester etc. are synthetic fiber and silk is one of the natural fibres which has no side effect on the body and costly items. Black braided silk surgical Suture is used in the hospital, Nursing homes for especial purpose in the surgical ward. There is good market demand. There is export demand of black braided silk Suture. Any new entrepreneur may make its own market by his own credit.
Plant capacity: 3000 Mtrs./DayPlant & machinery: Rs. 9.00 Lacs
Working capital: Rs. 41 LacsT.C.I: Rs. 70 Lacs
Return: 72.31%Break even: 30.99%
Add to Inquiry Add to Inquiry Basket

Blood Bags - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Blood bag is a disposable bio-medical device used for collection, storage, transportation and transfusion of human blood and blood components. The system consists of a single or multiple bag connecting with tubing, needle, needle cover, clamp etc. The blood bags are made of plastic material which are compatible with blood. In recent times, blood bags have become a conspicuous item and essential need of hospitals and nursing homes to meet blood infusion emergencies. Blood bags are most ostensibly serving the medical field in crucial hour. As the number of hospitals, nursing homes are increasing, the demand for the blood bags too is increasing tremendously.
Plant capacity: 3000nos./DayPlant & machinery: 164 Lakhs
Working capital: -T.C.I: 291 Lakhs
Return: 35.72%Break even: 48.65%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical (Biotech Traditional and Genetic) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunitiy

Pharmaceutical industry is a very large industry, which is producing different types of basic medicines by using specific microbial cells for specific products. Microbial cells are grown is the fermenter in the presence of nutrients in aseptic conditions. In case of generic biotechnology there is much more use of specific genetic code and genetic code is the indicator of the main working rule group. In treatment of any specific man or living organism, first, the genetic code will be judged and also behaviour of the genetic nature, then will be treatment using genetic kits. There is a good scope of genetic technology in the commerce.
Plant capacity: 1 Ton/Day PenicillinPlant & machinery: Rs. 2031.50 Lacs
Working capital: Rs. 155.44 LacsT.C.I: Rs. 3176.32 Lacs
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Bovine Serum Albumin - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Albumin?s are water soluble proteins which are found in both plant & animal tissues. Legumelin in leumes and leucosia in various cereals are examples of plant albumin?s whereas oval bomin, serum albumin etc. are the example of animal albumin. Bovine serum albumin is separated by dialysis. There is necessary to apply lyophilized process for manufacturing and separation of bovine albumin. There is necessity to take proper precautions and aseptic condition during commercial manufacturing process. Though the indigenous technology is available in India, but there is necessary to import plant and machineries. It has good market demand which is increasing day by day. It can be used mainly for the exchange of blood plasma in medical science. As a whole this project is good one for new comers.
Plant capacity: 1.50 Kgs/DayPlant & machinery: Rs. 99 Lakhs
Working capital: Rs. 32 LakhsT.C.I: Rs. 190 Lakhs
Return: 43.58%Break even: 46.12%
Add to Inquiry Add to Inquiry Basket

Sorbitol - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Sorbital is in the form of white crystalline solid or 70% aqueous colourless, odourless syrup with sweet taste. In majority of applications. 70% aqueous sorbitol is used. It is uses as raw material for the manufacture of vitamin C and also as basic additive material in tooth paste, creams, cosmetics, paper and numerous food products. The present installed capacity for sorbitol in the country is around 60000 tonnes per annum. Around 300 tonnes per annum is exported. The demand for sorbitol is tremendously increase. New sorbitol project can be install immediately on the basis of demand.
Plant capacity: 40.0 Tonnes/DayPlant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Ciprofloxacin - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Drug and pharmaceutical industry is one of the basis industries of India. Recent moves in globalization and liberalization has affected this industry perhaps the highest. Pharmaceutical industry has close linkages with imports of material and technology of process know-how and therefore with international economic. The industry started with manufacture of formulation from imported drugs in early 1940s. After independence with a view to ensure availability of good quality drugs at reasonable prices. Ciprofloxacin is used as anti bacterial drug or some time it is used as antibiotics. It is manufactured in India by few organized sectors as well as many private companies are engaged in the production of this product. There is very good indigenous demand as well as there is good export demand is available. So it can be concluded that any new entrepreneur may enter in this field with success.
Plant capacity: 300 Kgs./DayPlant & machinery: Rs. 44.0 Lakhs
Working capital: Rs. 130.0 LakhsT.C.I: Rs. 231.0 Lakhs
Return: 66.49%Break even: 35.01%
Add to Inquiry Add to Inquiry Basket

Implantable Surgical Suture (Biomedical Textile)- Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

A fibrous protein comprising most of the white fiber in the connective tissue of animals and man, especially in the skin muscles and tendous. The most abundant proline is the animal kingdom, it is rich in proline and hydroxyproline collagen is found in connective tissue and also in bones. Connective tissue is widely distributed throughout the body in such structures as the dermis, tendous, ligaments, cartilage and the matrix of bone. Surgical suture or biomedical textile is prepared from the fish collagen There are different fish available in India in abundance. Raw materials to process fish skin are also available but expertise is not easily available. Protein and fat wastes are generated which can be utilized to manufacture protein extract and fish oil. Biodegradable waste can be used for fish or poultry feed. Market is very good for quality products.
Plant capacity: 50 Kg/DayPlant & machinery: Rs. 81.95 Lacs
Working capital: Rs. 14.32 LacsT.C.I: Rs. 192.91 Lacs
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 2 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top